The activation of protein kinase activity of PERK has been demonstrated to activate Glycogen synthase kinase 3 beta (GSK3β), a major contributor of tau hyperphosphorylation in AD patients, in cell culture studies [352]. This evidence concerns the gene MAPT and Alzheimer disease.